These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36604023)

  • 21. [Research advances in primary biliary cholangitis].
    Duan WJ; Jia JD
    Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):801-804. PubMed ID: 29325271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New name and new treatments for primary biliary cholangitits].
    Bossen L; Ytting H; Jepsen P; Hamberg O; Ott P; Grønbæk H
    Ugeskr Laeger; 2018 Mar; 180(10):. PubMed ID: 29536837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis.
    Chapman RW
    Br J Hosp Med (Lond); 2018 Aug; 79(8):460-464. PubMed ID: 30070957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic fatigue should not be overlooked in primary biliary cholangitis.
    Shahini E; Ahmed F
    J Hepatol; 2021 Sep; 75(3):744-745. PubMed ID: 33640400
    [No Abstract]   [Full Text] [Related]  

  • 25. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.
    Hirschfield GM; Dyson JK; Alexander GJM; Chapman MH; Collier J; Hübscher S; Patanwala I; Pereira SP; Thain C; Thorburn D; Tiniakos D; Walmsley M; Webster G; Jones DEJ
    Gut; 2018 Sep; 67(9):1568-1594. PubMed ID: 29593060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
    Yuan Z; Jia G; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of liver inflammation on whole body insulin resistance : a case report on primary biliary cholangitis.
    Clarembeau F; Komuta M; Horsmans Y; Lanthier N
    Acta Gastroenterol Belg; 2019; 82(4):536-538. PubMed ID: 31950811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
    Schattenberg JM
    Gut; 2020 Aug; 69(8):1377-1378. PubMed ID: 32205421
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
    Sherlock S
    Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practical management of primary biliary cholangitis.
    Parés A;
    Rev Esp Enferm Dig; 2022 Jul; 114(7):410-417. PubMed ID: 34663072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis.
    Takemoto R; Miyake Y; Harada K; Nakanuma Y; Moriya A; Ando M; Hirohata M; Yamamoto K
    Intern Med; 2014; 53(13):1429-33. PubMed ID: 24990335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?].
    Saló J; Caballería L; Bruguera M; Parés A; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):5-10. PubMed ID: 9072202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geoepidemiology and changing mortality in primary biliary cholangitis.
    Floreani A; Tanaka A; Bowlus C; Gershwin ME
    J Gastroenterol; 2017 Jun; 52(6):655-662. PubMed ID: 28365879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment.
    March-Rodriguez A; Marcantonio O; Olmos-Alpiste F; Pujol RM
    Australas J Dermatol; 2022 Feb; 63(1):e49-e51. PubMed ID: 34905624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenges of primary biliary cholangitis: What is new and what needs to be done.
    Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D; Vierling JM; Adams D; Alpini G; Banales JM; Beuers U; Björnsson E; Bowlus C; Carbone M; Chazouillères O; Dalekos G; De Gottardi A; Harada K; Hirschfield G; Invernizzi P; Jones D; Krawitt E; Lanzavecchia A; Lian ZX; Ma X; Manns M; Mavilio D; Quigley EM; Sallusto F; Shimoda S; Strazzabosco M; Swain M; Tanaka A; Trauner M; Tsuneyama K; Zigmond E; Gershwin ME
    J Autoimmun; 2019 Dec; 105():102328. PubMed ID: 31548157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary biliary cholangitis associated with warm autoimmune hemolytic anemia.
    Gonzalez-Moreno EI; Martinez-Cabriales SA; Cruz-Moreno MA; Borjas-Almaguer OD; Cortez-Hernandez CA; Bosques-Padilla FJ; Garza AA; Gonzalez-Gonzalez JA; Garcia-Compean D; Ocampo-Candiani J; Maldonado-Garza HJ
    J Dig Dis; 2016 Feb; 17(2):128-31. PubMed ID: 26630456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Biliary Cholangitis-associated Palmar Keratosis.
    Usami J
    Intern Med; 2021 Sep; 60(17):2877. PubMed ID: 33746168
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnosis and treatment of primary biliary cirrhosis.
    Kim KA; Jeong SH
    Korean J Hepatol; 2011 Sep; 17(3):173-9. PubMed ID: 22102382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary biliary cirrhosis and ursodeoxycholic acid therapy].
    Makino I
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):399-403. PubMed ID: 8691003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.